Page 92 - Services Task Force News Today

Anticipates record fourth-quarter revenue, expects full-year 2024 revenue of $2.83 billion, submits next-generation Cologuard® to FDA Announces Chief Financial...

Using a new technology developed at MIT, diagnosing lung cancer could become as easy as inhaling nanoparticle sensors and then taking a urine test that reveals whether a tumor is present.

The diagnostic, which requires only a simple urine test to read the results, could make lung cancer screening more accessible worldwide

The nanosensors approach has the potential to substitute or complement the current gold standard, low-dose computed tomography (CT), in diagnosing lung cancer.

No easy algorithm for men who prefer to watch, rather than treat, their prostate cancers.

MITs tech makes lung cancer diagnosis simple: Inhale nanoparticle sensors, followed by a revealing urine test.

MITs tech makes lung cancer diagnosis simple: Inhale nanoparticle sensors, followed by a revealing urine test.

Using a new MIT technology, diagnosing lung cancer could become as easy as inhaling a sensor and then taking a urine test that reveals whether a tumor is present.

The University of Maryland, Baltimore (UMB) is the state’s public health, law, and human services university devoted to excellence in professional and graduate education, research, patient care, and public service.

Health experts recommend prioritizing these five cancer screenings during the new year.